GENEVA, Sept. 24 -- DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY filed a patent application (KR2025/023214) for “USE OF ERYTHROPOIETIN-DERIVED PEPTIDE FOR TREATING CEREBROVASCULAR DISEASES OR SEQUELAE CAUSED THEREBY”. With publication no. WO/2026/197537, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/10
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....